ENZND — Viskase Holdings, Inc.
—
OTC ·
Health Care ·
Biotechnology ·
CIK 727510 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 364,356,000 | -17,268,000 | -65,494,000 | 402,142,000 | 257,782,000 | — | 12,998,000 |
| Dec 2024 | 403,775,000 | 17,800,000 | -5,360,000 | — | — | — | 3,369,000 |
| Dec 2023 | 445,984,000 | 39,721,000 | 13,506,000 | — | — | — | 44,165,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $181.31B | $335.94 | — |
| GILD | GILEAD SCIENCES, INC. | $166.04B | $133.73 | — |
| ARGX | ARGENX SE | $50.27B | $808.43 | — |
| RVMD | Revolution Medicines, Inc. | $32.93B | $154.89 | — |
| BIIB | BIOGEN INC. | $28.51B | $193.08 | — |
Recent Insider Activity
No insider activity indexed for this ticker.